000538 云南白药
交易中 01-09 13:27:42
资讯
新帖
简况
每周股票复盘：云南白药（000538）预计2026年与上海医药关联交易达19亿元
证券之星 · 01-02
每周股票复盘：云南白药（000538）预计2026年与上海医药关联交易达19亿元
云南白药：已将仿冒情况转交相关部门
证券之星 · 2025-12-31
云南白药：已将仿冒情况转交相关部门
上海医药拟与云南白药续签关联交易协议，2026年双向交易额上限19亿元
中金财经 · 2025-12-31
上海医药拟与云南白药续签关联交易协议，2026年双向交易额上限19亿元
上海医药拟与云南白药续签19亿元上限关联交易协议，销售采购双向合作
财中社 · 2025-12-29
上海医药拟与云南白药续签19亿元上限关联交易协议，销售采购双向合作
上海医药拟续签云南白药框架协议 2026年销售上限12亿元、采购上限7亿元
美股速递 · 2025-12-29
上海医药拟续签云南白药框架协议 2026年销售上限12亿元、采购上限7亿元
股市必读：云南白药（000538）12月26日董秘有最新回复
证券之星 · 2025-12-29
股市必读：云南白药（000538）12月26日董秘有最新回复
云南白药：截至2025年三季度末股东总数166,806户
证券之星 · 2025-12-26
云南白药：截至2025年三季度末股东总数166,806户
云南白药：12月12日接受机构调研，红思客资产、深圳世纪量子等多家机构参与
证券之星 · 2025-12-16
云南白药：12月12日接受机构调研，红思客资产、深圳世纪量子等多家机构参与
云南白药集团连续三年荣获上市公司董办最佳实践
云南白药官微 · 2025-12-07
云南白药集团连续三年荣获上市公司董办最佳实践
云南白药斩获CGMA“年度最佳管理会计实践”大奖，彰显行业标杆实力
云南白药官微 · 2025-12-02
云南白药斩获CGMA“年度最佳管理会计实践”大奖，彰显行业标杆实力
云南白药新注册《小分子和蛋白质具体相互作用预测工具V1.0》项目的软件著作权
证券之星 · 2025-11-15
云南白药新注册《小分子和蛋白质具体相互作用预测工具V1.0》项目的软件著作权
云南白药新注册《小分子过敏反应风险预测工具V1.0》项目的软件著作权
证券之星 · 2025-11-12
云南白药新注册《小分子过敏反应风险预测工具V1.0》项目的软件著作权
云南白药最新公告：选举张文学为董事长
证券之星 · 2025-11-10
云南白药最新公告：选举张文学为董事长
每周股票复盘：云南白药（000538）Q3净利增0.55%，股东户数增3.52%
证券之星 · 2025-11-02
每周股票复盘：云南白药（000538）Q3净利增0.55%，股东户数增3.52%
云南白药（000538）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 2025-11-01
云南白药（000538）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
云南白药(000538.SZ)发布前三季度业绩，归母净利润47.77亿元，增长10.41%
智通财经 · 2025-10-30
云南白药(000538.SZ)发布前三季度业绩，归母净利润47.77亿元，增长10.41%
云南白药（000538）披露拟取消监事会并修订公司章程议案，10月27日股价上涨0.2%
证券之星 · 2025-10-27
云南白药（000538）披露拟取消监事会并修订公司章程议案，10月27日股价上涨0.2%
每周股票复盘：云南白药（000538）新华都发行20亿可交换债
证券之星 · 2025-10-26
每周股票复盘：云南白药（000538）新华都发行20亿可交换债
云南白药（000538）披露持股5％以上股东非公开发行可交换公司债券发行完成公告，10月23日股价上涨0.21%
证券之星 · 2025-10-23
云南白药（000538）披露持股5％以上股东非公开发行可交换公司债券发行完成公告，10月23日股价上涨0.21%
云南白药：云南白药胶囊常用于跌打损伤、瘀血肿痛等
证券日报 · 2025-09-30
云南白药：云南白药胶囊常用于跌打损伤、瘀血肿痛等
加载更多
公司概况
公司名称：
云南白药集团股份有限公司
所属行业：
医药制造业
上市日期：
1993-12-15
主营业务：
云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品、批发零售、农产品。2025年上半年，云南白药第16年上榜财富中文网发布的《财富中国500强排行榜》，位列第357位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。
发行价格：
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":57.23,"timestamp":1767936462000,"preClose":57.21,"halted":0,"volume":4609851,"delay":0,"changeRate":0.0003,"floatShares":1773000000,"shares":1784000000,"eps":2.9143,"marketStatus":"交易中","change":0.02,"latestTime":"01-09 13:27:42","open":57.18,"high":57.45,"low":57.03,"amount":264000000,"amplitude":0.0073,"askPrice":57.24,"askSize":11,"bidPrice":57.23,"bidSize":1,"shortable":0,"etf":0,"ttmEps":2.9143,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1767942000000},"marketStatusCode":2,"adr":0,"adjPreClose":57.21,"symbolType":"stock","openAndCloseTimeList":[[1767922200000,1767929400000],[1767934800000,1767942000000]],"highLimit":62.93,"lowLimit":51.49,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"isCdr":false,"pbRate":2.57,"roa":"--","peRate":19.637649,"roe":"11.92%","epsLYR":2.66,"committee":-0.191223,"marketValue":102113000000,"turnoverRate":0.0026,"status":0,"floatMarketCap":101457000000},"requestUrl":"/m/hq/s/000538","defaultTab":"news","newsList":[{"id":"2600356870","title":"每周股票复盘：云南白药（000538）预计2026年与上海医药关联交易达19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600356870","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600356870?lang=zh_cn&edition=full","pubTime":"2026-01-02 01:44","pubTimestamp":1767289454,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：云南白药预计2026年与上海医药日常关联交易总额为190,000.00万元。预计2026年与上海医药日常关联交易总额为190,000.00万元，占公司最近一期经审计净资产的4.89%，无需提交股东会审议。2025年实际发生关联交易总额为109,929.20万元，未超审批额度。关于2026年度预计日常关联交易的公告云南白药预计2026年度与上海医药发生日常关联交易总额为190,000.00万元，其中向其采购商品预计120,000.00万元，销售商品预计70,000.00万元，交易价格参照市场价格协商确定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","LU1993786604.SGD","BK1197","BK0196","BK0028","LU1807302812.USD","BK0187","BK0184","BK0099","BK0175","02607","601607","BK0012","LU1960683339.HKD","BK0097","BK0164","BK0020","BK0209","000538","BK0188","BK0239"],"gpt_icon":1},{"id":"2595722949","title":"云南白药：已将仿冒情况转交相关部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2595722949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595722949?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:42","pubTimestamp":1767170545,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药(000538)12月31日在投资者关系平台上答复投资者关心的问题。投资者提问：云南草本牙膏，云南本草喷雾剂明显仿冒白药产品，严重损害白药品牌价值，公司如何拿出有效举措打击市面上的低端仿造产品？云南白药回复：感谢您对我们品牌维权工作的关注与支持。公司始终高度重视知识产权保护，设有专项团队负责侵权处理工作。我们已将您反应的情况转交至相关部门。若您有其他线索或疑问，欢迎随时拨打我们的品牌维权专线：0871-66225010。再次感谢您的支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100028575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0188","LU1960683339.HKD","BK0196","BK0187","BK0164","BK0239","LU1807302812.USD","BK0175","000538","LU1993786604.SGD"],"gpt_icon":0},{"id":"2595745414","title":"上海医药拟与云南白药续签关联交易协议，2026年双向交易额上限19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595745414","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595745414?lang=zh_cn&edition=full","pubTime":"2025-12-31 08:05","pubTimestamp":1767139521,"startTime":"0","endTime":"0","summary":"中访网数据 上海医药集团股份有限公司于2025年12月29日召开董事会，审议通过了与关联方云南白药集团股份有限公司续签《日常关联交易/持续关连交易框架协议》的议案。根据协议，在2026年1月1日至2026年12月31日期间，上海医药向云南白药销售产品的金额上限为人民币12亿元，向云南白药采购产品的金额上限为人民币7亿元，双向交易总额上限合计19亿元。云南白药目前持有上海医药17.95%的股份，为其第二大股东，构成关联关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251231/31906320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0188","BK0209","BK0184","BK0099","BK0196","LU1960683339.HKD","BK0164","BK0183","BK0028","000538","601607","BK0239","BK0187","BK0012","LU1993786604.SGD","BK0097","BK0020","LU1807302812.USD","BK1197","BK0175","02607"],"gpt_icon":0},{"id":"2595783594","title":"上海医药拟与云南白药续签19亿元上限关联交易协议，销售采购双向合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2595783594","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595783594?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:22","pubTimestamp":1766996528,"startTime":"0","endTime":"0","summary":"12月29日，上海医药（601607/02607）发布公告，公司拟与云南白药（000538）续签日常关联交易/持续关连交易框架协议。根据协议，2026年公司向云南白药销售产品金额上限为12亿元，向云南白药采购产品金额上限为7亿元。云南白药持有公司17.95%的股份，为公司第二大股东，是公司的关联方。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512293604442415.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0020","02607","BK0175","LU1807302812.USD","601607","BK0183","BK0099","000538","BK0028","LU1960683339.HKD","BK0196","BK0187","BK0097","BK1197","BK0164","BK0012","BK0184","LU1993786604.SGD","BK0209","BK0188","BK0239"],"gpt_icon":0},{"id":"1145701636","title":"上海医药拟续签云南白药框架协议 2026年销售上限12亿元、采购上限7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145701636","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145701636?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:58","pubTimestamp":1766995115,"startTime":"0","endTime":"0","summary":"，中文，长度不超过4096字符，这里肯定没问题。检查是否符合所有要求：股票名称正确，关键信息保留，改写后流畅，有节奏感，无语法错误，中文表达自然。上海医药宣布，公司计划与云南白药续签框架协议。根据协议安排，2026年上海医药对云南白药的销售额上限将设定为12亿元，同期向云南白药的采购额上限则为7亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1993786604.SGD","BK0196","BK0012","LU1960683339.HKD","601607","LU1807302812.USD","000538","BK0020","BK0209","BK0183","BK0097","BK0239","BK0164","BK0184","BK0099","BK0175","BK0028","BK0188","BK0187"],"gpt_icon":0},{"id":"2595273706","title":"股市必读：云南白药（000538）12月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2595273706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595273706?lang=zh_cn&edition=full","pubTime":"2025-12-29 01:46","pubTimestamp":1766943972,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，云南白药报收于56.7元，下跌0.11%，换手率0.28%，成交量4.99万手，成交额2.83亿元。董秘最新回复投资者： 你好，公司被举牌了，是哪个机构或资本？截至2025年三季度末公司普通股股东总数为166,806户，谢谢！例如非独立懂事、独立董事的个人详细介绍资料董秘： 您好！投资者： 请问公司截至10月31日的股东人数是多少，谢谢董秘： 您好！当日关注点来自交易信息汇总：12月26日主力资金净流出1827.96万元，散户资金净流入2226.11万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900000617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1807302812.USD","LU1993786604.SGD","BK0164","BK0175","BK0012","000538","LU1960683339.HKD","BK0188","BK0239","BK0028","BK0196","BK0187"],"gpt_icon":0},{"id":"2594267459","title":"云南白药：截至2025年三季度末股东总数166,806户","url":"https://stock-news.laohu8.com/highlight/detail?id=2594267459","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594267459?lang=zh_cn&edition=full","pubTime":"2025-12-26 16:51","pubTimestamp":1766739081,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药(000538)12月26日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，最新股东人数是多少云南白药回复：您好！截至2025年三季度末公司普通股股东总数为166,806户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600023039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","000538","LU1807302812.USD","BK0188","BK0239","BK0175","BK0187","BK0028","BK0164","BK0196","LU1993786604.SGD","LU1960683339.HKD"],"gpt_icon":0},{"id":"2591757106","title":"云南白药：12月12日接受机构调研，红思客资产、深圳世纪量子等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2591757106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591757106?lang=zh_cn&edition=full","pubTime":"2025-12-16 09:10","pubTimestamp":1765847402,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年12月15日云南白药发布公告称公司于2025年12月12日接受机构调研，红思客资产、深圳世纪量子龚鸣 袁志强 吴世国 周一雄 陈建伟 王晨烨 朱靓 茹萍 左华军 余军 黎伟欣 陈觅 利志华、广州顺从投资、深圳奇创集团、投资者参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600006484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0188","LU1993786604.SGD","BK0196","LU1960683339.HKD","BK0028","BK0164","LU1807302812.USD","000538","BK0187","BK0175"],"gpt_icon":0},{"id":"2589870677","title":"云南白药集团连续三年荣获上市公司董办最佳实践","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870677","media":"云南白药官微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589870677?lang=zh_cn&edition=full","pubTime":"2025-12-07 20:37","pubTimestamp":1765111020,"startTime":"0","endTime":"0","summary":"12月3日，中国上市公司协会发布“上市公司董办最佳实践案例征集活动”结果，云南白药集团荣获2025上市公司董事会办公室最佳实践，实现连续三年荣获该项殊荣。2025上市公司董办最佳实践案例征集活动于今年10月启动，经初审、专家委员会评审、诚信核查等环节，最终评出最佳实践案例344家，优秀实践案例316家。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyswc3252206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1993786604.SGD","BK0164","BK0175","BK0196","BK0239","LU1960683339.HKD","BK0012","BK0028","000538","BK0187","BK0188","LU1807302812.USD"],"gpt_icon":0},{"id":"2588057037","title":"云南白药斩获CGMA“年度最佳管理会计实践”大奖，彰显行业标杆实力","url":"https://stock-news.laohu8.com/highlight/detail?id=2588057037","media":"云南白药官微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588057037?lang=zh_cn&edition=full","pubTime":"2025-12-02 18:15","pubTimestamp":1764670500,"startTime":"0","endTime":"0","summary":"凭借在管理会计领域的深度创新与卓越实践，云南白药集团股份有限公司成功斩获“年度最佳管理会计实践”奖项，这一荣誉不仅是国际权威机构对云南白药集团财经管理工作的高度认可，更标志着云南白药在数字化转型与业财融合领域的实践已跻身行业前列。云南白药集团从众多实力强劲的参评企业中脱颖而出，充分印证了云南白药集团管理会计实践的硬核实力与行业示范价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-02/doc-infzmifc1000338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1960683339.HKD","BK0187","BK0175","000538","BK0028","BK0188","LU1807302812.USD","LU1993786604.SGD","BK0012","BK0196","BK0239","BK0164"],"gpt_icon":0},{"id":"2583162683","title":"云南白药新注册《小分子和蛋白质具体相互作用预测工具V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2583162683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583162683?lang=zh_cn&edition=full","pubTime":"2025-11-15 00:30","pubTimestamp":1763137838,"startTime":"0","endTime":"0","summary":"证券之星消息，近日云南白药（000538）新注册了《小分子和蛋白质具体相互作用预测工具V1.0》项目的软件著作权。今年以来云南白药新注册软件著作权2个。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了1.56亿元，同比增5.31%。通过天眼查大数据分析，云南白药集团股份有限公司共对外投资了35家企业，参与招投标项目20547次；财产线索方面有商标信息3254条，专利信息546条，著作权信息77条；此外企业还拥有行政许可1240个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111500000188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","LU1807302812.USD","LU1960683339.HKD","BK0164","BK0239","BK0187","BK0012","000538","BK0175","BK0196","LU1993786604.SGD"],"gpt_icon":0},{"id":"2582764396","title":"云南白药新注册《小分子过敏反应风险预测工具V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2582764396","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582764396?lang=zh_cn&edition=full","pubTime":"2025-11-12 01:51","pubTimestamp":1762883472,"startTime":"0","endTime":"0","summary":"证券之星消息，近日云南白药（000538）新注册了《小分子过敏反应风险预测工具V1.0》项目的软件著作权。今年以来云南白药新注册软件著作权1个。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了1.56亿元，同比增5.31%。通过天眼查大数据分析，云南白药集团股份有限公司共对外投资了35家企业，参与招投标项目20547次；财产线索方面有商标信息3254条，专利信息546条，著作权信息77条；此外企业还拥有行政许可1240个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200000975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0239","000538","BK0164","BK0187","BK0028","LU1993786604.SGD","BK0196","LU1960683339.HKD","BK0012","BK0188","LU1807302812.USD"],"gpt_icon":0},{"id":"2582820412","title":"云南白药最新公告：选举张文学为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2582820412","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582820412?lang=zh_cn&edition=full","pubTime":"2025-11-10 19:20","pubTimestamp":1762773619,"startTime":"0","endTime":"0","summary":"云南白药(000538.SZ)公告称，公司第十一届董事会2025年第一次会议于11月10日召开，选举张文学为董事长，董明为副董事长，任期三年。同时，会议选举产生了各专门委员会委员及主任委员。第十一届董事会成员包括非独立董事张文学、董明、郭昕、游光辉、谢云山、上官常川、李科，以及独立董事刘国恩、纳超洪、胡明星、曹仰锋。职工董事杨帆的公示期已截止，将正式履职。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000028488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0187","BK0164","BK0196","BK0028","LU1960683339.HKD","000538","BK0188","LU1993786604.SGD","LU1807302812.USD","BK0012","BK0239"],"gpt_icon":0},{"id":"2580473659","title":"每周股票复盘：云南白药（000538）Q3净利增0.55%，股东户数增3.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580473659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580473659?lang=zh_cn&edition=full","pubTime":"2025-11-02 02:06","pubTimestamp":1762020372,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，云南白药报收于56.66元，较上周的56.36元上涨0.53%。股本股东变化截至2025年9月30日，云南白药股东户数为16.68万户，较6月30日增加5676户，增幅3.52%。业绩披露要点云南白药2025年三季报显示，前三季度主营收入306.54亿元，同比上升2.47%；归母净利润47.77亿元，同比上升10.41%；扣非净利润45.5亿元，同比上升6.68%。本次质押后，新华都及其一致行动人累计质押股份14850万股，占其合计持股33.03%，占公司总股本8.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","LU1993786604.SGD","BK0175","BK0196","BK0012","BK0164","BK0239","LU1807302812.USD","BK0187","LU1960683339.HKD","000538","BK0188"],"gpt_icon":0},{"id":"2580295412","title":"云南白药（000538）2025年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2580295412","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580295412?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:35","pubTimestamp":1761950103,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期云南白药发布2025年三季报。截至本报告期末，公司营业总收入306.54亿元，同比上升2.47%，归母净利润47.77亿元，同比上升10.41%。本报告期云南白药盈利能力上升，毛利率同比增幅5.84%，净利率同比增幅7.94%。报告期内，实现营业收入212.57亿元，较上年同期增长3.92%；实现归母净利润36.33亿元，较上年同期的31.89亿元同比增长13.93%，创同期历史新高；扣非归母净利润34.61亿元，较上年同期的31.35亿元同比增长10.40%，创同期历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"gpt_icon":0},{"id":"2579487121","title":"云南白药(000538.SZ)发布前三季度业绩，归母净利润47.77亿元，增长10.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579487121","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579487121?lang=zh_cn&edition=full","pubTime":"2025-10-30 23:42","pubTimestamp":1761838924,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云南白药(000538.SZ)发布2025年三季度报告，该公司前三季度营业收入为306.54亿元，同比增长2.47%。归属于上市公司股东的净利润为47.77亿元，同比增长10.41%。归属于上市公司股东的扣除非经常性损益的净利润为45.5亿元，同比增长6.68%。基本每股收益为2.68元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"云南白药(000538.SZ)发布前三季度业绩，归母净利润47.77亿元，增长10.41%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000538"],"gpt_icon":0},{"id":"2578161649","title":"云南白药（000538）披露拟取消监事会并修订公司章程议案，10月27日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578161649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578161649?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:17","pubTimestamp":1761556673,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，云南白药报收于56.47元，较前一交易日上涨0.2%，最新总市值为1007.57亿元。公司近日发布公告称，将于2025年11月10日召开2025年第二次临时股东大会，审议包括关于取消监事会并修订《公司章程》的议案、修订《股东大会议事规则》和《董事会议事规则》的议案，以及选举第十一届董事会非独立董事和独立董事的累积投票议案。上述议案已获第十届董事会2025年第六次会议审议通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700023736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1993786604.SGD","BK0028","BK0175","BK0188","BK0164","LU1807302812.USD","BK0012","BK0187","BK0239","LU1960683339.HKD","BK0196","000538"],"gpt_icon":0},{"id":"2578050400","title":"每周股票复盘：云南白药（000538）新华都发行20亿可交换债","url":"https://stock-news.laohu8.com/highlight/detail?id=2578050400","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578050400?lang=zh_cn&edition=full","pubTime":"2025-10-26 02:46","pubTimestamp":1761417972,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，云南白药报收于56.36元，较上周的57.06元下跌1.23%。本周，云南白药10月20日盘中最高价报57.34元。公司公告汇总关于持股5％以上股东非公开发行可交换公司债券发行完成的公告云南白药集团股份有限公司于2025年10月23日收到持股5%以上股东新华都实业集团股份有限公司通知，其非公开发行的可交换公司债券已完成发行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002264","BK0239","BK0188","BK0187","BK0102","BK0175","BK0012","000538","BK0028","LU1993786604.SGD","LU1807302812.USD","BK0209","BK0137","BK0093","BK0164","BK0070","BK0210","BK0217","BK0196","BK0170","LU1960683339.HKD"],"gpt_icon":0},{"id":"2577583888","title":"云南白药（000538）披露持股5％以上股东非公开发行可交换公司债券发行完成公告，10月23日股价上涨0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577583888","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577583888?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:10","pubTimestamp":1761228646,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，云南白药报收于56.57元，较前一交易日上涨0.21%，最新总市值为1009.36亿元。该股当日开盘56.38元，最高56.57元，最低56.21元，成交额达3.13亿元，换手率为0.31%。根据近日发布的公告，云南白药集团股份有限公司于2025年10月23日收到持股5%以上股东新华都实业集团股份有限公司的书面通知，其非公开发行的可交换公司债券已完成发行。公司将继续履行相关信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300037650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0175","BK0239","BK0012","BK0164","BK0028","LU1960683339.HKD","BK0188","LU1993786604.SGD","BK0187","LU1807302812.USD","000538"],"gpt_icon":0},{"id":"2571465073","title":"云南白药：云南白药胶囊常用于跌打损伤、瘀血肿痛等","url":"https://stock-news.laohu8.com/highlight/detail?id=2571465073","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571465073?lang=zh_cn&edition=full","pubTime":"2025-09-30 17:36","pubTimestamp":1759224960,"startTime":"0","endTime":"0","summary":"证券日报网讯云南白药9月30日在互动平台回答投资者提问时表示，云南白药胶囊常用于跌打损伤、瘀血肿痛，各种出血，疮疡肿毒及软组织挫伤，闭合性骨折，及皮肤感染性疾病。请严格按照说明书或遵医嘱使用。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-30/doc-infshnvn8017696.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-30/doc-infshnvn8017696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0175","BK0239","BK0188","BK0028","BK0187","000538","BK0196","BK0164","BK0012"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767936465427,"stockEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":0.0288},{"period":"3month","weight":-0.0021},{"period":"6month","weight":0.0386},{"period":"1year","weight":0.0328},{"period":"ytd","weight":0.0079}],"compareEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":0.0444},{"period":"3month","weight":0.0477},{"period":"6month","weight":0.1632},{"period":"1year","weight":0.264},{"period":"ytd","weight":0.0288}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"166806人(较上一季度增加3.52%)","perCapita":"10627股","listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","registeredCapital":"178426万元","survey":" 云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品、批发零售、农产品。2025年上半年，云南白药第16年上榜财富中文网发布的《财富中国500强排行榜》，位列第357位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。","listedPrice":3.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}